Document is current
Any future updates will be listed below
-
Authors
Heinrich, Marieke https://orcid.org/0009-0008-3526-8601
Kosmala, Aleksander https://orcid.org/0000-0002-9313-9356
Dierks, Alexander
Genest, Franca https://orcid.org/0000-0001-6233-4805
Gerhard-Hartmann, Elena https://orcid.org/0000-0003-2134-2774
Haug, Lukas https://orcid.org/0009-0008-8714-327X
Achtziger, Silke
Raab, Peter https://orcid.org/0000-0001-6063-5831
Buck, Andreas K. https://orcid.org/0000-0002-6447-0613
Lapa, Constantin https://orcid.org/0000-0001-7536-2207
Michalski, Kerstin https://orcid.org/0000-0001-8715-7788
Seefried, Lothar https://orcid.org/0000-0003-1154-3388
-
Funding
Funding for this research was provided by:
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (Z-2/CSP-32)
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (Z-3BC/08)
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 22 September 2025
Revised: 20 March 2026
Accepted: 25 March 2026
First Online: 4 May 2026
Declarations
:
: The local Ethics Committee of Julius-Maximilians University, Wuerzburg, Germany waived the need for further approval due to the retrospective character of the study (waiver no. 20241002 01).
: Lothar Seefried has received honoraria for consultation and lectures from Alexion/AstraZeneca, AM-Pharma, Amgen, Biomarin, Chiesi, Gedeon-Richter, Haleon/GSK, Inozyme, KyowaKirin, Mereo, Novartis, Stadapharm, Theramex, UCB and Ultragenyx; and grants for scientific projects to the institution from Alexion/AstraZeneca, Chiesi, and KyowaKirin. Franca Genest received speaker honoraria from Abbvie, Alexion, Lilly. Constantin Lapa reports prior consulting activities for Blue Earth Diagnostics Ltd., PentixaPharm, Pfizer, and Novartis. Kerstin Michalski reports prior consulting activities for Novartis.
